1Therapeutic Goods (Prescription Medicines—Transparency Measures) Specification 2020

---

meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8

?xml version="1.0" encoding="utf-8" standalone="no"?>

Commonwealth Coat of Arms of Australia

 

Therapeutic Goods (Prescription Medicines—Transparency Measures) Specification 2020

I, John Skerritt, as delegate of the Minister for Health, make the following specification.

Dated 17 December 2020

Adjunct Professor John Skerritt

Deputy Secretary

Health Products Regulation Group

Department of Health

 

 

 

Contents

1  Name

2  Commencement

3  Authority

4  Definitions

5  Release of therapeutic goods information

Schedule 1—Specified kinds of therapeutic goods information

 

 

1  Name

  This instrument is the Therapeutic Goods (Prescription Medicines—Transparency Measures) Specification 2020.

2  Commencement

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

• Commencement information
• Column 1 Column 2 Column 3
• Provisions Commencement Date/Details
• 1. The whole of this instrument 1 January 2021. 1 January 2021

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under subsection 61(5D) of the Therapeutic Goods Act 1989.

4  Definitions

Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:

(a) indications;

(b) medicine;

(c) passed preliminary assessment;

(d) registered goods;

(e) Secretary; and